Hamid Sayar
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Archeology top 2%
- Forensic Anthropology and Bioarchaeology Studies
Papers in
- Hematology 31
- Acute Myeloid Leukemia Research 28
- Chronic Myeloid Leukemia Treatments 7
- Multiple Myeloma Research and Treatments 6
-
- Histone Deacetylase Inhibitors Research 9
- Cancer therapeutics and mechanisms 2
- Co-authors
- A. Silvana Santachiara‐Benerecetti (1 shared paper)Alfredo Coppa (1 shared paper)Aisha Mohyuddin (1 shared paper)R. Spencer Wells (1 shared paper)Doron M. Behar (1 shared paper)Raphaëlle Chaix (1 shared paper)Qasim Ayub (1 shared paper)Chris Tyler‐Smith (1 shared paper)
- Journals
- Blood (9 papers)Investigational New Drugs (2 papers)Leukemia Research (2 papers)American Journal of Hematology (2 papers)Journal of Clinical Oncology (2 papers)
- Partner nations
- United StatesFranceSpain
In The Last Decade
Hamid Sayar
34 papers receiving 629 citations
Peers
Comparison fields: 5 of 81
- Hematology 169
- Archeology 125
- Genetics 269
- Genetics 71
- Molecular Biology 250
Countries citing papers authored by Hamid Sayar
This map shows the geographic impact of Hamid Sayar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hamid Sayar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hamid Sayar more than expected).
Fields of papers citing papers by Hamid Sayar
This network shows the impact of papers produced by Hamid Sayar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hamid Sayar. The network helps show where Hamid Sayar may publish in the future.
Co-authors
The 25 scholars most cited alongside Hamid Sayar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 317 | |
| 2 | 2019 | 53 | |
| 3 | 2013 | 44 | |
| 4 | 2011 | 33 | |
| 5 | 2016 | 29 | |
| 6 | 2017 | 27 | |
| 7 | 2005 | 24 | |
| 8 | 2016 | 17 | |
| 9 | 2017 | 13 | |
| 10 | 2021 | 11 | |
| 11 | 2011 | 10 | |
| 12 | 2006 | 9 | |
| 13 | 2021 | 6 | |
| 14 | 2014 | 5 | |
| 15 | 2011 | 5 | |
| 16 | 2021 | 5 | |
| 17 | 2012 | 5 | |
| 18 | 2015 | 5 | |
| 19 | Chronic myeloid leukemia within a year of kidney transplant with elevated alkaline phosphatase correlated with imatinib therapy. | 2011 | 4 |
| 20 | 2014 | 3 |
About Hamid Sayar
Hamid Sayar is a scholar working on Hematology, Molecular Biology, Genetics, Public Health, Environmental and Occupational Health and Pulmonary and Respiratory Medicine, having authored 36 papers that have together received 648 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (28 papers), Histone Deacetylase Inhibitors Research (9 papers), Chronic Myeloid Leukemia Treatments (7 papers), Multiple Myeloma Research and Treatments (6 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers), Acute Lymphoblastic Leukemia research (4 papers), Hemoglobinopathies and Related Disorders (3 papers) and Cancer therapeutics and mechanisms (2 papers). The work is most often cited by research in Hematology (169 citations), Archeology (125 citations), Genetics (269 citations), Genetics (71 citations) and Molecular Biology (250 citations). Hamid Sayar has collaborated with scholars based in United States, France and Spain. Frequent co-authors include A. Silvana Santachiara‐Benerecetti, Alfredo Coppa, Aisha Mohyuddin, R. Spencer Wells, Doron M. Behar, Raphaëlle Chaix, Qasim Ayub, Chris Tyler‐Smith, Nadia Al-Zahery and S. Qasim Mehdi. Their work appears in journals such as Blood, Investigational New Drugs, Leukemia Research, American Journal of Hematology and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.